FROM ONE NEWS NOW/AFA

Activist: HRC engaging in corporate 'blackmail'


Charlie Butts - OneNewsNow - 10/20/2010 3:55:00 AM

A prominent pro-homosexual group isn't satisfied with benefits already being offered by 337 major American businesses to their homosexual employees.

General Motors, Bank of America, IBM, Ford Motor, AT&T, Walgreen Co., Target, Citigroup -- those companies (and scores more) got a 100-percent favorable rating on the 2010 Corporate Equality Index [PDF], an annual business ranking published by the Human Rights Campaign (HRC), the largest homosexual activist organization in the country. [Caution: The previous link goes to a pro-homosexual website]

But HRC is now demanding those corporations offer unlimited healthcare coverage for transgender employees -- or lose the highest ranking offered under the Corporate Equality Index. Peter LaBarbera of Americans for Truth About Homosexuality tells OneNewsNow the group is simply escalating "its blackmail campaign against businesses."

"In order to get a 100-percent rating, you now have to provide funding for sex-change operations for transsexuals," he explains. "So...they keep ramping up the demands to get the 100-percent rating, knowing that companies are bragging about having the rating."

Which, according to LaBarbera, means that people who spend money with those firms are helping underwrite that health coverage.

The Americans for Truth spokesman says even more to be concerned about. "An official in the Obama administration is also telling gay activists to lobby for transsexual sex-change operations to be covered under ObamaCare," he claims.

LaBarbera points out that homosexuals represent one to three percent of the total population -- and transsexuals are only a fraction of that group.

In an interview with CitizenLink, the president of the National Association for Research and Therapy for Homosexuality urged caution regarding HRC's costly new requirement. "Medical treatments for transgender issues are very risky procedures -- and it's an irreversible path to take," said Dr. Julie Hamilton. "There should be a lot more research done before these types of procedures become the main path to take."